Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1345099 · FYE Jun 30 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $14.55Day +2.97%1Y −6.8%Off 52W high −32.3%Vol (1Y) 56.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,669 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.2% of sh out |
| Days to cover11.0d |
| 13F net flow (QoQ)−0.02% |
| Top-10 13F concentration76.6% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$17.2M |
| Earnings (TTM)-$102.1M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−19.3% |
| 1Y−6.8% |
| 3Y+81.9% |
| 5Y+3.9% |
| 10Y+73.6% |
| Since incept. (ann.)−1.0% |
Price return through 2026-07-30 · series begins 2015-11-13. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)56.5% |
| Ann. volatility (3Y)97.6% |
| Sharpe (1Y)0.12 |
| Sharpe (3Y)0.69 |
| Max drawdown (1Y)−37.1% |
| Max drawdown (3Y)−78.5% |
| Beta (3Y vs SPY)1.58 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 630,855 | $10M | — | −6.7% |
| MORGAN STANLEY | 514,431 | $8M | — | −13.8% |
| GOLDMAN SACHS GROUP INC | 397,215 | $6M | — | +0.3% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 386,472 | $6M | — | −10.1% |
| UBS Group AG | 132,573 | $2M | — | +82.7% |
| BANK OF AMERICA CORP /DE/ | 100,004 | $2M | — | +608.4% |
| JANE STREET GROUP, LLC | 98,786 | $2M | — | −41.0% |
| Penbrook Management LLC | 87,075 | $1M | — | −0.6% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.
No reported quarters on file for MESO.
